Literature DB >> 33560469

Proteomic Profiling of Cerebrum Mitochondria, Myelin Sheath, and Synaptosome Revealed Mitochondrial Damage and Synaptic Impairments in Association with 3 × Tg-AD Mice Model.

Liming Shen1, Aochu Yang2, Xinqian Chen2, Shifeng Xiao2, Xukun Liu2, Jing Lin2,3, Yuxi Zhao2, Kaoyuan Zhang2, Cuihua Li2, Junyan Ke2, Huajie Zhang2,4, Naseer Ullah Khan2,5.   

Abstract

Alzheimer's disease (AD) is the most common age-associated dementia with complex pathological hallmarks. Mitochondrion, synaptosome, and myelin sheath appear to be vulnerable and play a key role in the pathogenesis of AD. To clarify the early mechanism associated with AD, followed by subcellular components separation, we performed iTRAQ (isobaric tags for relative and absolute quantification)-based proteomics analysis to simultaneously investigate the differentially expressed proteins (DEPs) within the mitochondria, synaptosome, and myelin sheath in the cerebrum of the 6-month-old triple transgenic AD (3 × Tg-AD) and 6-month-old wild-type (WT) mice. A large number of DEPs between the AD and WT mice were identified. Most of them are related to mitochondria and synaptic dysfunction and cytoskeletal protein change. Differential expressions of Lrpprc, Nefl, and Sirpa were verified by Western blot analysis. The results suggest that decreased energy metabolism, impaired amino acid metabolism and neurotransmitter synthesis, increase compensatory fatty acid metabolism, up-regulated cytoskeletal protein expression, and oxidative stress are the early events of AD. Among these, mitochondrial damage, synaptic dysfunction, decreased energy metabolism, and abnormal amino acid metabolism are the most significant events. The results indicate that it is feasible to separate and simultaneously perform proteomics analysis on the three subcellular components.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Mitochondrion; Myelin sheath; Synaptosome; iTRAQ

Mesh:

Substances:

Year:  2021        PMID: 33560469     DOI: 10.1007/s10571-021-01052-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  82 in total

Review 1.  Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Qian Cai; Prasad Tammineni
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease.

Authors:  Johannes Brettschneider; Axel Petzold; Daniel Schottle; Annett Claus; Matthias Riepe; Hayrettin Tumani
Journal:  Dement Geriatr Cogn Disord       Date:  2006-02-10       Impact factor: 2.959

3.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

Authors:  Alessandra Castegna; Michael Aksenov; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

Review 4.  Cytoskeletal pathologies of Alzheimer disease.

Authors:  James R Bamburg; George S Bloom
Journal:  Cell Motil Cytoskeleton       Date:  2009-08

5.  Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

Authors:  Mehtap Bacioglu; Luis F Maia; Oliver Preische; Juliane Schelle; Anja Apel; Stephan A Kaeser; Manuel Schweighauser; Timo Eninger; Marius Lambert; Andrea Pilotto; Derya R Shimshek; Ulf Neumann; Philipp J Kahle; Matthias Staufenbiel; Manuela Neumann; Walter Maetzler; Jens Kuhle; Mathias Jucker
Journal:  Neuron       Date:  2016-06-09       Impact factor: 17.173

6.  Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice.

Authors:  Jenna C Carroll; Emily R Rosario; Lilly Chang; Frank Z Stanczyk; Salvatore Oddo; Frank M LaFerla; Christian J Pike
Journal:  J Neurosci       Date:  2007-11-28       Impact factor: 6.167

Review 7.  Cytoplasmic dynein: a key player in neurodegenerative and neurodevelopmental diseases.

Authors:  Xiang-Jun Chen; Huan Xu; Helen M Cooper; Yaobo Liu
Journal:  Sci China Life Sci       Date:  2014-03-24       Impact factor: 6.038

Review 8.  Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View.

Authors:  Giovanna Cenini; Ana Lloret; Roberta Cascella
Journal:  Oxid Med Cell Longev       Date:  2019-05-09       Impact factor: 6.543

9.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Hubert Hackl; Pornpimol Charoentong; Marie Tosolini; Amos Kirilovsky; Wolf-Herman Fridman; Franck Pagès; Zlatko Trajanoski; Jérôme Galon
Journal:  Bioinformatics       Date:  2009-02-23       Impact factor: 6.937

10.  PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.

Authors:  Idoia Blanco-Luquin; Miren Altuna; Javier Sánchez-Ruiz de Gordoa; Amaya Urdánoz-Casado; Miren Roldán; María Cámara; Victoria Zelaya; María Elena Erro; Carmen Echavarri; Maite Mendioroz
Journal:  Clin Epigenetics       Date:  2018-09-12       Impact factor: 6.551

View more
  2 in total

1.  Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation.

Authors:  Savannah E Kandigian; Elizabeth C Ethier; Robert R Kitchen; Tukiet T Lam; Steven E Arnold; Becky C Carlyle
Journal:  Brain Commun       Date:  2022-04-21

2.  Protective Effect of Dictyophora Polysaccharides on Sodium Arsenite-Induced Hepatotoxicity: A Proteomics Study.

Authors:  Ting Hu; Liming Shen; Qun Huang; Changyan Wu; Huajie Zhang; Qibing Zeng; Guoze Wang; Shaofeng Wei; Shuling Zhang; Jun Zhang; Naseer Ullah Khan; Xiangchun Shen; Peng Luo
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.